Qingdao Haier Biomedical Co.,Ltd.’s Net Profit Dropped 21.3% in First Three Quarters of 2023

Qingdao Haier Biomedical Co.,Ltd. (青岛海尔生物医疗股份有限公司) (688139.SH) reported a net profit of 365.6 million yuan in the first three quarters of 2023, down 21.3% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, down 12% year-on-year.

At the end of the reporting period, it had 5.5 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 19.6%.